Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ikonomidou

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Metabolic Brain Disease|June 1, 1996
Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonistsC Ikonomidou, L Turski
Journal of Child Neurology|January 16, 1998
Glutamate in neurologic diseasesP Bittigau, C Ikonomidou
Critical Reviews in Neurobiology|January 1, 1996
Neurodegenerative disorders: clues from glutamate and energy metabolismC Ikonomidou, L Turski
Current Opinion in Neurology|December 1, 1995
Excitotoxicity and neurodegenerative diseasesC Ikonomidou, L Turski
Annals of the New York Academy of Sciences|November 25, 1997
Pharmacology of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo-(F)-quinoxalineC Ikonomidou, L Turski
Current Opinion in Neurology|September 15, 2000
Mechanisms of neurodegeneration after paediatric brain injuryU Felderhoff-Mueser, C Ikonomidou
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2000
Neuronal death enhanced by N-methyl-D-aspartate antagonistsC Ikonomidou, V Stefovska, L Turski
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2001
Glutamate antagonists limit tumor growthW Rzeski, L Turski, C Ikonomidou
Brain Research|May 15, 1989
Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant ratsC Ikonomidou, J L Mosinger, J W Olney
Amino Acids|November 7, 2013
Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatumW A Turski, E Urbańska, M Sieklucka, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Metabolic Brain Disease|June 1, 1996
Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonistsC Ikonomidou, L Turski
Journal of Child Neurology|January 16, 1998
Glutamate in neurologic diseasesP Bittigau, C Ikonomidou
Critical Reviews in Neurobiology|January 1, 1996
Neurodegenerative disorders: clues from glutamate and energy metabolismC Ikonomidou, L Turski
Current Opinion in Neurology|December 1, 1995
Excitotoxicity and neurodegenerative diseasesC Ikonomidou, L Turski
Annals of the New York Academy of Sciences|November 25, 1997
Pharmacology of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo-(F)-quinoxalineC Ikonomidou, L Turski
Current Opinion in Neurology|September 15, 2000
Mechanisms of neurodegeneration after paediatric brain injuryU Felderhoff-Mueser, C Ikonomidou
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2000
Neuronal death enhanced by N-methyl-D-aspartate antagonistsC Ikonomidou, V Stefovska, L Turski
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2001
Glutamate antagonists limit tumor growthW Rzeski, L Turski, C Ikonomidou
Brain Research|May 15, 1989
Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant ratsC Ikonomidou, J L Mosinger, J W Olney
Amino Acids|November 7, 2013
Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatumW A Turski, E Urbańska, M Sieklucka, et al.
Pageof 6